Consultants

EXPERT PANEL

MEADERS: Medication Events and Adverse Drug Events Recording System

Meeting: APRIL 5-6, 2006

Rockville, MD

Expert	Area of Expertise
Alan Lembitz, MD	Vice President of COPIC and the Director of Risk Management. Assists physicians in risk reduction and practice improvement that both improves care and lowers overall malpractice risk.
Diane Cousins, RPh	Developed the US Pharmacopeia Practitioners’ Reporting Network into four nationwide reporting programs that focus on the quality, efficacy, and safety of over-the-counter and prescription drugs used in human and veterinary medicine.
Gurdev Singh, MD	Director of Patient Safety Research Center at SUNY-Buffalo. Civil engineer with a background in safety in primary care. He has designed a web-based error reporting system.
Harold Kaplan, MD	Professor of Clinical Pathology and Director of Transfusion Medicine at the Columbia University Medical Center. Current research effort is directed at establishing the usefulness of standardized medical event reporting for error prevention and management throughout healthcare delivery systems.
Kathleen Stevens, RN, EdD	Professor at the University of Texas Health Science Center School of Nursing, Family Care Department and the Graduate School of Biomedical Sciences and a Certified Advance Practice Nurse. Her research includes children’s health promotion, evidence synthesis, evidence-based practice, and informatics applications.
Kim Galt, PhD	Professor of Pharmacy, developed and managed pharmacists’ primary care consultative ambulatory practice sites in the private and Veternas Affairs systems, supervised specialized drug information and clinical pharmacy services, and practiced general hospital, community and long-term care pharmacy.
Mark Lehto, PhD	Associate Professor and Industrial engineer whose research focuses on human decision-making, hazard communication, safety and ergonomics. His work in the area of product warning and instructions is nationally recognized.
Michael Cohen, RPh, MS, ScD	President of the Institute for Safe Medication Practices (ISMP), member of the Drug Safety and Risk Management Advisory Panel for the U.S. Food and Drug Administration (FDA), the committee on identifying and preventing medication errors for the Institute of Medicine, and the national Quality Forum’s National Voluntary Consensus Standards Maintenance Committee on Safe Practices.
Morris Weinberger, PhD	Professor of HealthCare quality at the University of North Carolina, Chapel Hill. A behavioral scientist who has performed at number of interventional and observational studies involving drug therapy in PBRNs and community drugstores.
Ranjit Singh, MD, MBA	Director of Patient Safety Research Center at the Family Medicine Research Institute, SUNY-Buffalo. Experience in software development and systems engineering issues.
R. Scott Evans, PhD, MS	Director of Research for the Department of Clinical Epidemiology. Designs, develops and evaluates computerized tools for the selection and management of anti-infective agents, computer methods to identify and reduce adverse drug events, computerized methods to identify patients needing isolation, and computerized methods to identify and reduce hospital-acquired infections.